Skip to main content
×
Home
    • Aa
    • Aa

Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea

  • Clarwyn Yip (a1), Mark Loeb (a2) (a3), Suzette Salama (a1), Lorraine Moss (a2) and Jan Olde (a3)...
Abstract
Abstract<span class='bold'>Objective:</span>

To determine modifiable risk factors for nosocomial Clostridium difficile-associated diarrhea (CDAD).

<span class='bold'>Design:</span>

Case-control study.

<span class='bold'>Setting:</span>

300-bed tertiary-care hospital.

<span class='bold'>Participants:</span>

Hospital inpatients present during the 3-month study period.

<span class='bold'>Methods:</span>

Case-patients identified with nosocomial CDAD over the study period were compared to two sets of control patients: inpatients matched by age, gender, and date of admission; and inpatients matched by duration of hospital stay. Variables including demographic data, comorbid illnesses, antibiotic exposure, and use of gastrointestinal medications were assessed for case- and control-patients. Conditional logistic regression was performed to identify risk factors for nosocomial CDAD.

<span class='bold'>Results:</span>

27 case-patients were identified and were compared to the two sets of controls (1:1 match for each comparison set). For the first set of controls, use of ciprofloxacin (odds ratio [OR], 5.5; 95% confidence interval [CI95], 1.2-24.8; P=.03) was the only variable that remained significant in the multivariable model. For the second set of controls, prior exposure to cephalosporins (OR, 6.7; CL,5, 1.3-33.7; P=.02) and to ciprofloxacin (OR, 9.5; CI95, 1.01-88.4; P=.05) were kept in the final model.

<span class='bold'>Conclusions:</span>

Along with cephalosporins, prior quinolone use predisposed hospitalized patients to nosocomial CDAD. Quinolones should be used judiciously in acute-care hospitals, particularly in those where CDAD is endemic.

Copyright
Corresponding author
Hamilton Health Sciences Corporation, 711 Concession St, Hamilton, Ontario L8V1C3, Canada
References
Hide All
1.Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998;26:10271036.
2.Spencer RC. Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 1998;41(suppl):C5C12.
3.Wilcox M, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996;34:2330.
4.Schuller I, Saha V, Kingston J, Eden T, Tabaqchali S. Investigation and management of Clostridium difficile colonization in a paediatric oncology unit. Arch Dis Child 1995;72:219222.
5.Emoto M, Kawarabayashi T, Hachisuga T, Eguchi F, Shirakawa K. Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol Oncol 1996;61:369372.
6.Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998;129:10121019.
7.Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990;11:283290.
8.Aronsson B, Molby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-82. J Infect Dis 1985;151:476481.
9.Impallomeni M, Galletlt NP, Wort SJ, Starr JM, Rogers TR. Increased risk of diarrhea caused by Clostridium difficile in elderly patients receiving cefotaxime. BMJ 1995;311:13451346.
10.Delmee M, Avesani V. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile. Antimicrob Agents Chemother 1986;29:374375.
11.Chow AW, Cheng N, Bartlett KH. In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics. Antimicrob Agents Chemother 1985;28;842844.
12.McFarland LV, Bauwens JE, Melcher SA, Surawicz CM, Greenberg RN, Elmer GW. Ciprofloxacin-associated Clostridium difficile disease. Lancet 1995;346:977978.
13.Bates CJ, Wilcox MH, Spencer RC, Harris DM. Ciprofloxacin and Clostridium difficile infection. Lancet 1990;336:1193.
14.Cain DB, O'Connor ME. Pseudomembranous colitis associated with ciprofloxacin. Lancet 1990;336:946.
15.Ehrenpreis ED, Iievens MW, Craig RM. Clostridium difficile-associated diarrhea after norfloxacin. J Clin Gastroenterol 1990;12:188189.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 110 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd October 2017. This data will be updated every 24 hours.